Search results for "performance"

showing 10 items of 4457 documents

Media multitasking is associated with distractibility and increased prefrontal activity in adolescents and young adults.

2016

The current generation of young people indulges in more media multitasking behavior (e.g., instant messaging while watching videos) in their everyday lives than older generations. Concerns have been raised about how this might affect their attentional functioning, as previous studies have indicated that extensive mediamultitasking in everyday life may be associated with decreased attentional control. In the current study, 149 adolescents and young adults (aged 13-24 years) performed speech-listening and reading tasks that required maintaining attention in the presence of distractor stimuli in the othermodality or dividing attention between two concurrent tasks. Brain activity during task pe…

MaleBrain activity and meditationAudiologymedia multitaskingBrain mappingDevelopmental psychology0302 clinical medicineCOGNITIVE CONTROLTask Performance and AnalysisAttentionBRAINPLASTICITYEveryday lifeta515prefrontal cortexBrain Mappingmedicine.diagnostic_test05 social sciencesfMRIMultitasking BehaviorNeurologyMultimediaAuditory PerceptionFemalePsychologyRESPONSE-INHIBITIONpsychological phenomena and processesmedicine.medical_specialtyCORTEXAdolescent515 PsychologyCognitive NeurosciencePrefrontal CortexAffect (psychology)behavioral disciplines and activitiesta3112050105 experimental psychology03 medical and health sciencesYoung AdultWORKING-MEMORYmedicineHuman multitaskingHumans0501 psychology and cognitive sciencestarkkaavaisuusWorking memoryAttentional controlPERFORMANCEFRONTAL LESIONSMedia multitaskingLIFEReading516 Educational sciencesSUSTAINED ATTENTIONNerve NetFunctional magnetic resonance imaging030217 neurology & neurosurgeryNeuroImage
researchProduct

Reading skill and neural processing accuracy improvement after a 3-hour intervention in preschoolers with difficulties in reading-related skills

2012

This study aimed at determining whether an intervention game developed for strengthening phonological awareness has a remediating effect on reading skills and central auditory processing in 6-year-old preschool children with difficulties in reading-related skills. After a 3-hour training only, these children made a greater progress in reading-related skills than did their matched controls who did mathematical exercises following comparable training format. Furthermore, the results suggest that this brief intervention might be beneficial in modulating the neural basis of phonetic discrimination as an enhanced speech-elicited mismatch negativity (MMN) was seen in the intervention group, indic…

MaleBrain activity and meditationmedia_common.quotation_subjecteducationMismatch negativityRecognition (Psychology)behavioral disciplines and activitiesEarly Intervention (Education)050105 experimental psychologyDevelopmental psychologyDyslexia03 medical and health sciencesDiscrimination Psychological0302 clinical medicinePhoneticsPhonological awarenessEvent-related potentialIntervention (counseling)Reading (process)Early Intervention EducationalmedicineHumansRemedial Teaching0501 psychology and cognitive sciencesChildEvoked PotentialsMolecular Biologyta515media_commonAuditory CortexDiscrimination (Psychology)General Neuroscience05 social sciencesDyslexiaRecognition PsychologyElectroencephalographymedicine.diseaseGames ExperimentalReadingData Interpretation StatisticalAuditory PerceptionFemaleNeurology (clinical)Brief interventionPsychologyPsychomotor Performance030217 neurology & neurosurgeryDevelopmental BiologyBrain Research
researchProduct

Heterogeneity of executive functions among preschool children with psychiatric symptoms

2019

The aim of the present study was to investigate associations between internalizing and externalizing symptoms and deficits in executive functions (EF) as well as to examine the overall heterogeneity of EFs in a sample of preschool children attending a psychiatric clinic (n = 171). First, based on cut-off points signifying clinical levels of impairment on the parent-completed Child Behavior Checklist (CBCL), children were assigned into groups of internalizing, externalizing, combined or mild symptoms and compared to a reference group (n = 667) with regard to day care teacher ratings of EFs on the Attention and Executive Function Rating Inventory-Preschool (ATTEX-P). Second, latent profile an…

MaleCHILDHOODCBCLDay careExecutive functionsExecutive FunctionCOGNITIVE CONTROLDevelopmental and Educational PsychologyChild and adolescent psychiatryEFFORTFUL CONTROLTEACHER RATINGSChild Behavior ChecklistChildReference groupinternalizing symptomsPsychopathologyATTENTION-DEFICIT/HYPERACTIVITY DISORDERMental Disorders05 social sciencesExternalizing symptomsGeneral MedicineOriginal ContributionlastenpsykiatriaExecutive functionsexecutive functionspsychopathologyPsychiatry and Mental healthChild PreschoolInternalizing symptomsFemalePsychologypsykopatologia050104 developmental & child psychologyPsychopathologymedicine.medical_specialtytoiminnanohjaus (psykologia)PERFORMANCE-BASED MEASURES515 PsychologyINHIBITION050105 experimental psychologypreschoolexternalizing symptomsWORKING-MEMORYmedicineHumans0501 psychology and cognitive sciencesPsychiatrySet (psychology)PreschoolSELF-REGULATIONesikouluikäisetPediatrics Perinatology and Child Health
researchProduct

Frequent use of sugar products by schoolchildren in 20 European countries, Israel and Canada in 1993/1994

1999

The aim of this study was to describe the daily use of certain between-meal sugar products (soft drinks and sweets) of schoolchildren in 20 European countries, Israel and Canada as a part of the Cross-National Survey on Health Behaviour in School-Aged Children--a WHO Collaborative Study. The data were collected using standardised anonymous questionnaires in school classrooms during the 1993/1994 school year. In each country nationally or regionally representative samples of about 1,300 schoolchildren (450 in Greenland) were targeted. Use of sugar products was analysed according to sex, age, country, self-reported school performance and self-reported family economy. One third to one half of …

MaleCanadaAdolescentHealth BehaviorFrequency of useEthnic groupCarbonated BeveragesNorthern irelandWorld Health OrganizationSocial classCandyFamily economySex FactorsDietary SucroseSurveys and QuestionnairesEthnicityOdds RatioHumansIsraelChildSocioeconomicsGeneral DentistryAge FactorsReproducibility of ResultsOral health promotionFeeding BehaviorAchievementFrequent useEuropeGeographySchool performanceSocial ClassFemaleInternational Dental Journal
researchProduct

Characterization of DNA adducts at the bay region of dibenz[a,h]anthracene formed in vitro

1993

Bay region diolepoxide-DNA adducts of dibenz[a,h]anthracene (DBA) formed in vitro were identified and their absolute stereochemistry was assigned. After activation of [5,12-14C]DBA with liver microsomes obtained from Aroclor 1254 treated male Sprague-Dawley rats in the presence of calf thymus DNA for 1 h, the amount of DNA adducts was found to be 9.9 +/- 2.4 pmol/mg DNA, calculated on the basis of the portion of radioactivity eluted from the HPLC reversed-phase column with a water/acetonitrile gradient. Bay region diolepoxide-DNA adducts represented 27.5% of radioactivity associated with DNA adducts. The absolute configuration of the various adducts was determined from the reaction of the (…

MaleCancer ResearchAnthraceneMetaboliteAbsolute configurationStereoisomerismDNAGeneral MedicineIn Vitro TechniquesHigh-performance liquid chromatographyMedicinal chemistryRatsAdductRats Sprague-DawleyDNA Adductschemistry.chemical_compoundchemistryBiochemistryDeoxyadenosineBenz(a)AnthracenesMicrosomes LiverAnimalsDeoxyguanosineDibenz(ah)anthraceneBiotransformationCarcinogenesis
researchProduct

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

2018

Abstract Aim of the study The optimal therapeutic strategy in patients with rectal cancer and synchronous unresectable metastases remains unknown. We evaluated the efficacy of FOLFIRINOX induction therapy in this setting. Patients and methods Chemotherapy-naive patients received at least 8 cycles of FOLFIRINOX. The primary end-point was the 4-month disease control (4 m DC) rate. Tumour responses were centrally reviewed and assessed by computed tomography scan for metastases (Response Evaluation Criteria in Solid Tumours criteria) and magnetic resonance imaging for rectal tumorus. With a Simon 2-stage design and a targeted (H1) 4 m DC > 75%, 65 patients were enrolled from July 2012 to Februa…

MaleCancer ResearchLung NeoplasmsColorectal cancerFOLFIRINOXGastrointestinal DiseasesSynchronous metastasesLeucovorinKaplan-Meier EstimateInduction0302 clinical medicineInduction therapyAntineoplastic Combined Chemotherapy ProtocolsRectal cancerINDUCTION TREATMENTFatigueResponse rate (survey)medicine.diagnostic_testLiver NeoplasmsRemission InductionMiddle AgedCombined Modality TherapyMagnetic Resonance ImagingProgression-Free Survival3. Good healthOxaliplatinFOLFIRINOXTreatment OutcomeOncology030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemaleRadiologyFluorouracilAdultmedicine.medical_specialty[SDV.CAN]Life Sciences [q-bio]/CancerAdenocarcinomaIrinotecan03 medical and health sciencesmedicineHumansParesthesiaAgedPerformance statusbusiness.industryRectal NeoplasmsMagnetic resonance imagingmedicine.diseaseHematologic DiseasesConfidence intervalLocal controlbusinessTomography X-Ray ComputedFollow-Up Studies
researchProduct

Does pain intensity predict a poor opioid response in cancer patients?

2011

Abstract Aim The aim of this study was to test the hypothesis that initial pain intensity is not a predictive factor of poor opioid response in advanced cancer patients, as suggested by a recent work. Methods A secondary analysis of one-hundred-sixty-seven patients referred for treatment of cancer-related pain was conducted. Pain intensity at admission was recorded and patients were divided in three categories of pain intensity: mild, moderate and severe. Patients were offered a treatment with opioid dose titration, according to department policy. Data regarding opioid doses and pain intensity were collected after dose titration was completed. Four levels of opioid response were considered:…

MaleCancer ResearchOpioid responseopioid response in cancer patientPainOpioidSettore MED/42 - Igiene Generale E ApplicataSecondary analysisNeoplasmsmedicineHumansProspective StudiesCancer painKarnofsky Performance StatusAdverse effectAgedPain Measurementpain intensityAnalgesicsAnalysis of VarianceAssessment tools; Cancer pain; Opioid response; Aged; Analgesics Opioid; Analysis of Variance; Female; Humans; Karnofsky Performance Status; Male; Middle Aged; Neoplasms; Pain; Pain Measurement; Prospective Studies; Treatment Outcome; Cancer Research; Oncologybusiness.industryCancerMiddle Agedmedicine.diseaseAdvanced cancerIntensity (physics)Predictive factorAnalgesics OpioidAssessment toolsTreatment OutcomeOncologyOpioidAnesthesiapain intensity; opioid response in cancer patients; trial clinicoFemaletrial clinicoCancer painbusinessmedicine.drugEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic canc…

1996

Two doses of megestrol acetate (MA) have been prospectively compared in a random fashion as treatment for cancer-related anorexia-cachexia syndrome (ACS) in 122 patients with progressive soft tissue sarcoma, colorectal, lung, head and neck and renal cancer resistant to systemic chemotherapy. After 30 days of MA, 55% of patients receiving MA at 160 mg day-1 reported an increase in appetite, 27% of patients no variation and 18% complained of a decrease in appetite. Patients treated with MA at 320 mg day-1 reported an increase in appetite in 68% of cases, a stabilisation in 20% of cases and a decrease in 12%. Although an increase in appetite was more frequently observed in patients receiving M…

MaleCancer Researchmedicine.medical_specialtyCachexiamedia_common.quotation_subjectAppetiteAnorexiaGastroenterologyCachexiachemistry.chemical_compoundWeight lossNeoplasmsInternal medicinemedicineHumansProspective StudiesNeoplasm MetastasisProspective cohort studyAgedmedia_commonDose-Response Relationship DrugPerformance statusbusiness.industryMegestrol AcetateBody WeightAppetiteMegestrolSyndromeMiddle Agedmedicine.diseaseAnorexiaSurgeryOncologychemistryMegestrolMegestrol acetateFemalemedicine.symptombusinessResearch Articlemedicine.drugBritish Journal of Cancer
researchProduct

Symptom Expression in Patients with Advanced Cancer Admitted to an Acute Supportive/Palliative Care Unit With and Without Delirium

2018

Abstract Aim The aim of this study was to investigate the relationship between delirium and symptom expression in patients with advanced cancer admitted to an acute supportive/palliative care unit (ASPCU). Methods A consecutive sample of patients with advanced cancer who were admitted to an ASPCU was prospectively assessed for a period of 10 months. The Edmonton Symptom Assessment Scale (ESAS) and the MDAS (Memorial Delirium Assessment Scale) were measured at admission (T0) and after 7 days of palliative care (T7). Results Two hundred forty-six patients had complete data regarding MDAS measurements, at either T0 and T7. Of these, 75 (30.5%) and 63 patients (25.6%) had delirium at T0 and aft…

MaleCancer Researchmedicine.medical_specialtyWeaknessPalliative careNauseaNeuropsychological TestsSeverity of Illness Indexbehavioral disciplines and activities03 medical and health sciencesCognition0302 clinical medicineAdvanced cancerNeoplasmsInternal medicinemental disordersHumansMedicineProspective Studies030212 general & internal medicineKarnofsky Performance StatusDepression (differential diagnoses)Edmonton Symptom Assessment ScaleAgedNeoplasm StagingPain MeasurementDepressionbusiness.industryPalliative CareDeliriumCancerMemorial Delirium Assessment ScaleCancer PainMiddle Agedmedicine.diseaseAdvanced cancernervous system diseasesHospitalizationTreatment OutcomeOncologySymptom Management and Supportive Care030220 oncology & carcinogenesisBehavior Rating ScaleAnxietyDeliriumFemaleSymptom Assessmentmedicine.symptombusinessThe Oncologist
researchProduct

Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients.

2015

Thymidylate synthase (TS) poly-epitope peptide (TSPP) is a 27-mer peptide vaccine containing the amino acidic sequences of three epitopes with HLA-A2.1-binding motifs of TS, an enzyme overexpressed in cancer cells, which plays a crucial role in DNA repair and replication. Based on the results of preclinical studies, we designed a phase Ib trial (TSPP/VAC1) to investigate, in a dose escalation setting, the safety and the biological activity of TSPP vaccination alone (arm A) or in combination with GM-CSF and IL-2 (arm B) in cancer patients. Twenty-one pretreated metastatic cancer patients, with a good performance status (ECOG ≤ 1) and no severe organ failure or immunological disease, were enr…

MaleCancer Researchmedicine.medical_treatmentImmunologyPharmacologyThymidylate synthaseCancer VaccinesCTLsNeoplasmsCancer vaccineMedicineImmunology and AllergyHumansImmune responseAdverse effectAgedbiologyPerformance statusbusiness.industryPhase Ib trialCancerImmunotherapyThymidylate SynthaseMiddle Agedmedicine.diseaseCancer vaccine; CTLs; Immune response; Immunotherapy; Phase Ib trial; Cancer Research; Oncology; Immunology; Immunology and AllergyOncologyCTLImmunologyToxicityVaccines Subunitbiology.proteinPeptide vaccineFemaleCancer vaccineImmunotherapybusinessCancer immunology, immunotherapy : CII
researchProduct